Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Many CKD Patients Receive PICCs Despite Contraindications

By HospiMedica International staff writers
Posted on 10 Jun 2019
A new study reveals that close to a third of hospitalized patients who receive a peripherally inserted central catheter (PICC) suffer from advanced chronic kidney disease (CKD), despite contraindications.

Researchers at the VA Ann Arbor Healthcare System (MI, USA), the University of Michigan (U-M) Medical School (Ann Arbor, USA), and other institutions analyzed inpatient data from 52 hospitals in order to study PICC use in patients with CKD, despite contraindications that suggest they should be avoided so as to preserve future vascular access. More...
The primary outcome was percentage of PICC patients with an estimated glomerular filtration rate (GFR) indicating stage 3b or higher CKD.

The results revealed that of the 20,545 patients who had a PICC placed during their hospital stay, an average of 23.1% had CKD (32.1% in the ICU and 18.9% on the wards). Older patients were more likely to receive a PICC than younger patients, and 3.4% of patients on hemodialysis also had a PICC placed during their hospital stay. Multilumen PICCs were placed more frequently than single-lumen PICCs both in patients in the ICU and on the wards. Two thirds of the CKD patients had their PICC removed prior to hospital discharge. The study was published on June 4, 2019, in Annals of Internal Medicine.

“Vascular access is critical for patients with CKD, who may require renal replacement therapy. Yet despite guidelines that recommend against the use of PICCs in patients with CKD, we found that such practice is common and discordant with guidelines,” said lead author David Paje, MD, MPH, of U-M Medical School, and colleagues. “The most common complication associated with PICC use in patients with CKD was catheter occlusion. However, major complications, including venous thromboembolism and infection, were not uncommon.”

CKD is a progressive loss in kidney function that takes place over a period of months or even years. The symptoms of worsening kidney function are not specific, and might include feeling generally unwell and experiencing a reduced appetite. It is identified by a presence of creatinine, a breakdown product of muscle metabolism. Higher levels of creatinine indicate a lower GFR, resulting in a decreased capability of the kidneys to excrete waste products.

Related Links:
VA Ann Arbor Healthcare System
University of Michigan Medical School


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.